1. Home
  2. RLAY vs ATRO Comparison

RLAY vs ATRO Comparison

Compare RLAY & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$12.79

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo Astronics Corporation

ATRO

Astronics Corporation

HOLD

Current Price

$71.16

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
ATRO
Founded
2015
1968
Country
United States
United States
Employees
N/A
2700
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
RLAY
ATRO
Price
$12.79
$71.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
2
Target Price
$19.50
$86.00
AVG Volume (30 Days)
3.6M
350.5K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
31.78
N/A
EPS
N/A
N/A
Revenue
$15,355,000.00
N/A
Revenue This Year
N/A
$14.92
Revenue Next Year
$324.03
$8.81
P/E Ratio
N/A
N/A
Revenue Growth
53.44
N/A
52 Week Low
$2.71
$23.25
52 Week High
$17.32
$83.96

Technical Indicators

Market Signals
Indicator
RLAY
ATRO
Relative Strength Index (RSI) 45.40 48.19
Support Level $6.67 $70.72
Resistance Level $17.32 $79.86
Average True Range (ATR) 1.05 3.45
MACD -0.54 -0.52
Stochastic Oscillator 9.98 39.78

Price Performance

Historical Comparison
RLAY
ATRO

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

About ATRO Astronics Corporation

Astronics Corporation is a provider of technologies to the aerospace, defense, and electronics industries, offering high-performance electrical power generation and distribution systems, motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. The company operates through two reportable segments, Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the aerospace and defense industry and generates the majority of revenue, while the Test Systems segment designs, develops, manufactures, and maintains automated test systems for the aerospace and defense, communications, and mass transit industries. The company derives the majority of its revenue from the United States.

Share on Social Networks: